NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of investors that purchased or otherwise acquired Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ:IART) common stock between March 11, 2019 and May 22, 2023, inclusive (the "Class Period"). Click Here to Join Investigation.
If you acquired Integra common stock during the Class Period and would like to discuss this case, please click here. You may also contact us by emailing pmayer@kaplanfox.com or calling (646) 315-9003.
If you are a member of the proposed Class, you may move the court no later than November 13, 2023 to serve as a lead plaintiff for the purported class. If you have losses, we encourage you to contact us to learn more about the lead plaintiff process.
On May 23, 2023, Integra disclosed in ...